Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.01817843 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.01817843 |
3 | modulation by symbiont of host immune response (GO:0052553) | 6.01817843 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.01817843 |
5 | modulation by symbiont of host defense response (GO:0052031) | 6.01817843 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.01817843 |
7 | response to peptidoglycan (GO:0032494) | 5.53753660 |
8 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.46183383 |
9 | neutrophil activation involved in immune response (GO:0002283) | 5.24361542 |
10 | regulation of vitamin metabolic process (GO:0030656) | 4.95379448 |
11 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.78378514 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64422064 |
13 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.63771986 |
14 | positive regulation of interferon-alpha production (GO:0032727) | 4.57674976 |
15 | positive regulation of heat generation (GO:0031652) | 4.57100454 |
16 | regulation of chemokine biosynthetic process (GO:0045073) | 4.51368533 |
17 | regulation of fever generation (GO:0031620) | 4.50751376 |
18 | regulation of interferon-alpha production (GO:0032647) | 4.43223889 |
19 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.40369454 |
20 | macrophage activation involved in immune response (GO:0002281) | 4.38837089 |
21 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.35062690 |
22 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.30659091 |
23 | respiratory burst (GO:0045730) | 4.22971329 |
24 | superoxide anion generation (GO:0042554) | 4.18738322 |
25 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.16585817 |
26 | granulocyte activation (GO:0036230) | 4.12557530 |
27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.12341463 |
28 | response to host immune response (GO:0052572) | 4.12341463 |
29 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.08698656 |
30 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.07192472 |
31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.01489470 |
32 | myeloid dendritic cell differentiation (GO:0043011) | 3.89179464 |
33 | eosinophil chemotaxis (GO:0048245) | 3.89138503 |
34 | reactive oxygen species biosynthetic process (GO:1903409) | 3.87590617 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.87034811 |
36 | immunoglobulin mediated immune response (GO:0016064) | 3.85216839 |
37 | regulation of mononuclear cell migration (GO:0071675) | 3.80517088 |
38 | regulation of activation of Janus kinase activity (GO:0010533) | 3.78389229 |
39 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.71809033 |
40 | germinal center formation (GO:0002467) | 3.70973456 |
41 | negative regulation of viral genome replication (GO:0045071) | 3.70793040 |
42 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.69684169 |
43 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.69439520 |
44 | eosinophil migration (GO:0072677) | 3.68622519 |
45 | response to host (GO:0075136) | 3.68620270 |
46 | response to host defenses (GO:0052200) | 3.68620270 |
47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68620270 |
48 | cellular response to type I interferon (GO:0071357) | 3.67524280 |
49 | type I interferon signaling pathway (GO:0060337) | 3.67524280 |
50 | response to protozoan (GO:0001562) | 3.66728150 |
51 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.66384283 |
52 | response to type I interferon (GO:0034340) | 3.63542252 |
53 | neutrophil activation (GO:0042119) | 3.61590081 |
54 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.59038658 |
55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.58408165 |
56 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.58257379 |
57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57028535 |
58 | detection of molecule of bacterial origin (GO:0032490) | 3.56840217 |
59 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.56236756 |
60 | T-helper 1 type immune response (GO:0042088) | 3.56152573 |
61 | NIK/NF-kappaB signaling (GO:0038061) | 3.54942601 |
62 | positive regulation of mast cell degranulation (GO:0043306) | 3.52792682 |
63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52792682 |
64 | positive regulation of type 2 immune response (GO:0002830) | 3.51768552 |
65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.51276686 |
66 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.50891088 |
67 | natural killer cell mediated immunity (GO:0002228) | 3.50891088 |
68 | microglial cell activation (GO:0001774) | 3.48814638 |
69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.47852000 |
70 | leukocyte aggregation (GO:0070486) | 3.44505575 |
71 | cellular response to exogenous dsRNA (GO:0071360) | 3.44109878 |
72 | regulation of heat generation (GO:0031650) | 3.43910980 |
73 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.43394493 |
74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42704864 |
75 | negative regulation of interleukin-17 production (GO:0032700) | 3.41335613 |
76 | positive regulation of interferon-beta production (GO:0032728) | 3.40226042 |
77 | response to muramyl dipeptide (GO:0032495) | 3.37544683 |
78 | myeloid cell activation involved in immune response (GO:0002275) | 3.36366457 |
79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.35514630 |
80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.35246160 |
81 | regulation of interleukin-12 production (GO:0032655) | 3.34614608 |
82 | defense response to protozoan (GO:0042832) | 3.33069684 |
83 | regulation of immunoglobulin secretion (GO:0051023) | 3.30857460 |
84 | myeloid dendritic cell activation (GO:0001773) | 3.30771683 |
85 | cellular response to lipopolysaccharide (GO:0071222) | 3.30608838 |
86 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.30061538 |
87 | macrophage activation (GO:0042116) | 3.29078518 |
88 | cellular response to interferon-beta (GO:0035458) | 3.28960555 |
89 | regulation of chronic inflammatory response (GO:0002676) | 3.27981196 |
90 | regulation of mast cell degranulation (GO:0043304) | 3.26938839 |
91 | positive regulation of acute inflammatory response (GO:0002675) | 3.24647312 |
92 | positive regulation of interleukin-12 production (GO:0032735) | 3.23668682 |
93 | positive regulation of chemokine production (GO:0032722) | 3.22332755 |
94 | regulation of T-helper cell differentiation (GO:0045622) | 3.22332300 |
95 | negative regulation of interleukin-12 production (GO:0032695) | 3.22056544 |
96 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.21891258 |
97 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.21623611 |
98 | cellular response to molecule of bacterial origin (GO:0071219) | 3.21125396 |
99 | positive regulation of lymphocyte migration (GO:2000403) | 3.20014078 |
100 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.18865655 |
101 | regulation of podosome assembly (GO:0071801) | 3.17887658 |
102 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.16646788 |
103 | monocyte chemotaxis (GO:0002548) | 3.16122164 |
104 | positive regulation of mast cell activation (GO:0033005) | 3.15412088 |
105 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.13708131 |
106 | lymphocyte chemotaxis (GO:0048247) | 3.13307146 |
107 | negative regulation of growth of symbiont in host (GO:0044130) | 3.13260197 |
108 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.13260197 |
109 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.13260197 |
110 | regulation of growth of symbiont in host (GO:0044126) | 3.13260197 |
111 | positive regulation of antigen processing and presentation (GO:0002579) | 3.10099852 |
112 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10085185 |
113 | positive regulation of interleukin-6 production (GO:0032755) | 3.09738358 |
114 | response to interferon-alpha (GO:0035455) | 3.09623520 |
115 | glycosphingolipid catabolic process (GO:0046479) | 3.09401396 |
116 | regulation of interleukin-17 production (GO:0032660) | 3.08958993 |
117 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.08879769 |
118 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.08638210 |
119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.07938505 |
120 | dendritic cell differentiation (GO:0097028) | 3.07479473 |
121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07326424 |
122 | regulation of type 2 immune response (GO:0002828) | 3.07274352 |
123 | positive regulation of interleukin-10 production (GO:0032733) | 3.06699065 |
124 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.06100602 |
125 | cellular response to interferon-alpha (GO:0035457) | 3.05882582 |
126 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.05490371 |
127 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.04985387 |
128 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.04948940 |
129 | cellular extravasation (GO:0045123) | 3.04688083 |
130 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04222262 |
131 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.04220280 |
132 | leukocyte mediated cytotoxicity (GO:0001909) | 3.03797950 |
133 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03068369 |
134 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.02287474 |
135 | response to interferon-beta (GO:0035456) | 3.02021690 |
136 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01570039 |
137 | oligosaccharide catabolic process (GO:0009313) | 3.00403326 |
138 | negative regulation of lipid storage (GO:0010888) | 2.99879258 |
139 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.99617915 |
140 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91837257 |
141 | regulation of antigen processing and presentation (GO:0002577) | 2.91646324 |
142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.89749707 |
143 | activation of MAPKKK activity (GO:0000185) | 2.89406225 |
144 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.87880557 |
145 | cellular response to interferon-gamma (GO:0071346) | 2.87727586 |
146 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.85398618 |
147 | adhesion of symbiont to host cell (GO:0044650) | 2.84373986 |
148 | virion attachment to host cell (GO:0019062) | 2.84373986 |
149 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.82005405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.63164222 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.28828266 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.09934199 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.53229875 |
5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.26821619 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.16010568 |
7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.88654201 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.76555968 |
9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.66286143 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.64080852 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08163128 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98498596 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82615693 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.82054297 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.69415248 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58973178 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48968925 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33239306 |
19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.11798546 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95619478 |
21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86778492 |
22 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86299380 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84567512 |
24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78106843 |
25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71785330 |
26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.68677490 |
27 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63240788 |
28 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62523348 |
29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58780827 |
30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58408436 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57975465 |
32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55543182 |
33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47085917 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37790223 |
35 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37298306 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36958886 |
37 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29569947 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29409335 |
39 | * MYB_26560356_Chip-Seq_TH2_Human | 1.28068029 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26692945 |
41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26484151 |
42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25487325 |
43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25323343 |
44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23873700 |
45 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22878099 |
46 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22536031 |
47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17420438 |
48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16901773 |
49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16901773 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14973581 |
51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13782867 |
52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13721910 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13037879 |
54 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.11934082 |
55 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.11934082 |
56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.11934082 |
57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11029723 |
58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09930054 |
59 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.06998610 |
60 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06495864 |
61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06215855 |
62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05618842 |
63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05115568 |
64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05000591 |
65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04906797 |
66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04766834 |
67 | MAF_26560356_Chip-Seq_TH1_Human | 1.04119639 |
68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04031387 |
69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03253452 |
70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02671529 |
71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02171462 |
72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01765753 |
73 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01195409 |
74 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.00400029 |
75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99000268 |
76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98967338 |
77 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.98554501 |
78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98407029 |
79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97590207 |
80 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96061686 |
81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95879456 |
82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95396360 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95123058 |
84 | MYB_26560356_Chip-Seq_TH1_Human | 0.90737063 |
85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89913408 |
86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89520937 |
87 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89219938 |
88 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88413844 |
89 | MAF_26560356_Chip-Seq_TH2_Human | 0.87778774 |
90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87397224 |
91 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86692282 |
92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85220901 |
93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83535181 |
94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83114636 |
95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82175593 |
96 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81873020 |
97 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81873020 |
98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80335179 |
99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80317115 |
100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79621988 |
101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78877132 |
102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78439487 |
103 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78336451 |
104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.76633225 |
105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.74914890 |
106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74747030 |
107 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.73968608 |
108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72320065 |
109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.69330141 |
110 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68567229 |
111 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.66425729 |
112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.65606787 |
113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64151862 |
114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.64100768 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61250993 |
116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.60245214 |
117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.58942014 |
118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.58889572 |
119 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57602238 |
120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56050728 |
121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55491653 |
122 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.53925961 |
123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.52298982 |
124 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52130182 |
125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.51834592 |
126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.51584293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009785_altered_susceptibility_to | 4.61157430 |
2 | MP0001835_abnormal_antigen_presentation | 4.21579286 |
3 | MP0003436_decreased_susceptibility_to | 4.19771423 |
4 | MP0003303_peritoneal_inflammation | 4.15406518 |
5 | MP0002148_abnormal_hypersensitivity_rea | 4.08937070 |
6 | MP0006082_CNS_inflammation | 4.02385172 |
7 | * MP0005000_abnormal_immune_tolerance | 3.38883560 |
8 | * MP0002419_abnormal_innate_immunity | 3.37614921 |
9 | * MP0005025_abnormal_response_to | 3.21321024 |
10 | MP0005387_immune_system_phenotype | 2.66122056 |
11 | MP0001790_abnormal_immune_system | 2.66122056 |
12 | MP0002452_abnormal_antigen_presenting | 2.60481265 |
13 | MP0004510_myositis | 2.54596973 |
14 | MP0009764_decreased_sensitivity_to | 2.53630070 |
15 | * MP0003724_increased_susceptibility_to | 2.52519900 |
16 | * MP0002723_abnormal_immune_serum | 2.48797857 |
17 | MP0005671_abnormal_response_to | 2.46992404 |
18 | MP0000685_abnormal_immune_system | 2.46229017 |
19 | MP0002139_abnormal_hepatobiliary_system | 2.42504912 |
20 | MP0001800_abnormal_humoral_immune | 2.36605418 |
21 | * MP0001533_abnormal_skeleton_physiology | 2.25922100 |
22 | MP0001853_heart_inflammation | 2.17275362 |
23 | MP0003075_altered_response_to | 2.14842122 |
24 | MP0000343_altered_response_to | 2.10722490 |
25 | * MP0001819_abnormal_immune_cell | 2.10190835 |
26 | MP0005058_abnormal_lysosome_morphology | 2.09170063 |
27 | MP0005464_abnormal_platelet_physiology | 2.07281159 |
28 | * MP0002420_abnormal_adaptive_immunity | 2.05786571 |
29 | * MP0004947_skin_inflammation | 2.05446166 |
30 | MP0003448_altered_tumor_morphology | 2.03808463 |
31 | * MP0001845_abnormal_inflammatory_respons | 1.97370296 |
32 | MP0009278_abnormal_bone_marrow | 1.88905151 |
33 | MP0002405_respiratory_system_inflammati | 1.87959930 |
34 | MP0002006_tumorigenesis | 1.82140892 |
35 | * MP0008469_abnormal_protein_level | 1.75081901 |
36 | MP0010155_abnormal_intestine_physiology | 1.71903854 |
37 | MP0006054_spinal_hemorrhage | 1.64816362 |
38 | MP0005167_abnormal_blood-brain_barrier | 1.61864355 |
39 | MP0005166_decreased_susceptibility_to | 1.60234916 |
40 | MP0002998_abnormal_bone_remodeling | 1.57060763 |
41 | MP0009333_abnormal_splenocyte_physiolog | 1.56196990 |
42 | MP0000858_altered_metastatic_potential | 1.49084861 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.40029322 |
44 | MP0003806_abnormal_nucleotide_metabolis | 1.39793776 |
45 | MP0000604_amyloidosis | 1.39327750 |
46 | * MP0000716_abnormal_immune_system | 1.37484955 |
47 | MP0003172_abnormal_lysosome_physiology | 1.36802840 |
48 | MP0003828_pulmonary_edema | 1.34195185 |
49 | MP0005310_abnormal_salivary_gland | 1.32060880 |
50 | MP0003186_abnormal_redox_activity | 1.31558858 |
51 | MP0008004_abnormal_stomach_pH | 1.27527102 |
52 | MP0004782_abnormal_surfactant_physiolog | 1.25238955 |
53 | MP0001545_abnormal_hematopoietic_system | 1.22740263 |
54 | MP0005397_hematopoietic_system_phenotyp | 1.22740263 |
55 | MP0003195_calcinosis | 1.21466483 |
56 | * MP0002398_abnormal_bone_marrow | 1.18629635 |
57 | * MP0005164_abnormal_response_to | 1.17879712 |
58 | MP0004858_abnormal_nervous_system | 1.15049792 |
59 | MP0002277_abnormal_respiratory_mucosa | 1.14799693 |
60 | MP0003690_abnormal_glial_cell | 1.14632971 |
61 | * MP0005390_skeleton_phenotype | 1.14005363 |
62 | MP0003191_abnormal_cellular_cholesterol | 1.11554860 |
63 | MP0001542_abnormal_bone_strength | 1.06155453 |
64 | * MP0002429_abnormal_blood_cell | 1.05629310 |
65 | MP0009763_increased_sensitivity_to | 1.03813080 |
66 | MP0005076_abnormal_cell_differentiation | 1.02367637 |
67 | MP0001851_eye_inflammation | 1.02033332 |
68 | MP0002254_reproductive_system_inflammat | 1.01929872 |
69 | MP0009840_abnormal_foam_cell | 1.01707566 |
70 | MP0003300_gastrointestinal_ulcer | 1.00912988 |
71 | MP0000689_abnormal_spleen_morphology | 0.93275397 |
72 | MP0002332_abnormal_exercise_endurance | 0.92107217 |
73 | MP0005257_abnormal_intraocular_pressure | 0.91430838 |
74 | MP0005023_abnormal_wound_healing | 0.86024457 |
75 | * MP0002722_abnormal_immune_system | 0.84103288 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.82018613 |
77 | * MP0003453_abnormal_keratinocyte_physiol | 0.78572599 |
78 | MP0008874_decreased_physiological_sensi | 0.78357039 |
79 | MP0005647_abnormal_sex_gland | 0.77696488 |
80 | MP0005666_abnormal_adipose_tissue | 0.77501921 |
81 | MP0008260_abnormal_autophagy | 0.75885398 |
82 | MP0001501_abnormal_sleep_pattern | 0.75819991 |
83 | MP0010307_abnormal_tumor_latency | 0.74949902 |
84 | MP0003795_abnormal_bone_structure | 0.70994269 |
85 | MP0003329_amyloid_beta_deposits | 0.70489698 |
86 | MP0004808_abnormal_hematopoietic_stem | 0.69732543 |
87 | MP0003091_abnormal_cell_migration | 0.69073526 |
88 | MP0008438_abnormal_cutaneous_collagen | 0.68396470 |
89 | MP0003566_abnormal_cell_adhesion | 0.67834681 |
90 | MP0003763_abnormal_thymus_physiology | 0.66804420 |
91 | * MP0000249_abnormal_blood_vessel | 0.65278894 |
92 | MP0005266_abnormal_metabolism | 0.64956067 |
93 | MP0002136_abnormal_kidney_physiology | 0.63247641 |
94 | MP0000569_abnormal_digit_pigmentation | 0.62688628 |
95 | MP0010386_abnormal_urinary_bladder | 0.62236553 |
96 | MP0002877_abnormal_melanocyte_morpholog | 0.61190946 |
97 | MP0003045_fibrosis | 0.60882758 |
98 | MP0005165_increased_susceptibility_to | 0.59325185 |
99 | MP0000371_diluted_coat_color | 0.57501120 |
100 | MP0002166_altered_tumor_susceptibility | 0.56959799 |
101 | MP0005451_abnormal_body_composition | 0.56676139 |
102 | MP0003183_abnormal_peptide_metabolism | 0.54907412 |
103 | MP0003705_abnormal_hypodermis_morpholog | 0.54729884 |
104 | MP0001958_emphysema | 0.54728821 |
105 | MP0000920_abnormal_myelination | 0.54589931 |
106 | MP0002138_abnormal_hepatobiliary_system | 0.54034295 |
107 | MP0009765_abnormal_xenobiotic_induced | 0.53664618 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.52436915 |
109 | * MP0005535_abnormal_body_temperature | 0.52279082 |
110 | MP0001663_abnormal_digestive_system | 0.51668729 |
111 | MP0003646_muscle_fatigue | 0.51218418 |
112 | MP0000609_abnormal_liver_physiology | 0.50672927 |
113 | MP0002295_abnormal_pulmonary_circulatio | 0.50065911 |
114 | MP0005381_digestive/alimentary_phenotyp | 0.50007515 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.49946737 |
116 | * MP0002933_joint_inflammation | 0.49866113 |
117 | MP0005595_abnormal_vascular_smooth | 0.49463652 |
118 | MP0002693_abnormal_pancreas_physiology | 0.47652880 |
119 | MP0001764_abnormal_homeostasis | 0.47252832 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 7.85287568 |
2 | Recurrent abscess formation (HP:0002722) | 7.70227591 |
3 | Recurrent bacterial skin infections (HP:0005406) | 7.04382315 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.92211981 |
5 | Mediastinal lymphadenopathy (HP:0100721) | 5.73196706 |
6 | Abnormality of macrophages (HP:0004311) | 5.62110045 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.33567254 |
8 | Orchitis (HP:0100796) | 4.81074435 |
9 | Retrobulbar optic neuritis (HP:0100654) | 4.70128864 |
10 | Optic neuritis (HP:0100653) | 4.70128864 |
11 | Autoimmune thrombocytopenia (HP:0001973) | 4.61200681 |
12 | Gingivitis (HP:0000230) | 4.53037398 |
13 | Myositis (HP:0100614) | 4.46592175 |
14 | Loss of speech (HP:0002371) | 4.39086583 |
15 | Systemic lupus erythematosus (HP:0002725) | 4.26812405 |
16 | Recurrent skin infections (HP:0001581) | 4.23757638 |
17 | Obstructive lung disease (HP:0006536) | 4.21987244 |
18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.21987244 |
19 | Increased cerebral lipofuscin (HP:0011813) | 3.86026464 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.80776142 |
21 | Vasculitis (HP:0002633) | 3.75065387 |
22 | Recurrent fungal infections (HP:0002841) | 3.73571266 |
23 | Increased IgM level (HP:0003496) | 3.70975707 |
24 | Mutism (HP:0002300) | 3.70306896 |
25 | Nuclear cataract (HP:0100018) | 3.69417569 |
26 | Basal ganglia calcification (HP:0002135) | 3.57794634 |
27 | Vacuolated lymphocytes (HP:0001922) | 3.47006291 |
28 | Prostate neoplasm (HP:0100787) | 3.45812328 |
29 | Thick nail (HP:0001805) | 3.30683687 |
30 | Tetraparesis (HP:0002273) | 3.25464021 |
31 | Axonal loss (HP:0003447) | 3.24895523 |
32 | Urticaria (HP:0001025) | 3.21270806 |
33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.15159896 |
34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.15159896 |
35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.15159896 |
36 | Neurofibrillary tangles (HP:0002185) | 3.12894298 |
37 | Periodontitis (HP:0000704) | 3.08702704 |
38 | Pustule (HP:0200039) | 3.02629717 |
39 | Pulmonary infiltrates (HP:0002113) | 3.01645252 |
40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.00789414 |
41 | Cellulitis (HP:0100658) | 2.99017141 |
42 | Disinhibition (HP:0000734) | 2.98407469 |
43 | Recurrent viral infections (HP:0004429) | 2.97399786 |
44 | Mucopolysacchariduria (HP:0008155) | 2.96079914 |
45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.96079914 |
46 | Poor head control (HP:0002421) | 2.87119861 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78058918 |
48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78058918 |
49 | * Stomatitis (HP:0010280) | 2.76969932 |
50 | Apathy (HP:0000741) | 2.76756940 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.71235223 |
52 | Recurrent pneumonia (HP:0006532) | 2.69173394 |
53 | Keratoconjunctivitis sicca (HP:0001097) | 2.68143358 |
54 | Hypergammaglobulinemia (HP:0010702) | 2.67129847 |
55 | Diminished motivation (HP:0000745) | 2.65991886 |
56 | Peritonitis (HP:0002586) | 2.61680584 |
57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.61237718 |
58 | Myocardial infarction (HP:0001658) | 2.59564084 |
59 | Metaphyseal irregularity (HP:0003025) | 2.56082141 |
60 | Keratoconjunctivitis (HP:0001096) | 2.55740723 |
61 | Meningitis (HP:0001287) | 2.55546342 |
62 | Arterial thrombosis (HP:0004420) | 2.55297761 |
63 | Abnormality of the pericardium (HP:0001697) | 2.54983414 |
64 | Polyneuropathy (HP:0001271) | 2.54301636 |
65 | Inappropriate behavior (HP:0000719) | 2.51405465 |
66 | Nausea (HP:0002018) | 2.49851906 |
67 | Petechiae (HP:0000967) | 2.49748957 |
68 | Leukocytosis (HP:0001974) | 2.48802224 |
69 | Hemoptysis (HP:0002105) | 2.48796259 |
70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45817882 |
71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45817882 |
72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45817882 |
73 | Increased IgE level (HP:0003212) | 2.43995489 |
74 | Porencephaly (HP:0002132) | 2.43796479 |
75 | Progressive neurologic deterioration (HP:0002344) | 2.43055259 |
76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.41588337 |
77 | Premature loss of primary teeth (HP:0006323) | 2.41410974 |
78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.39518277 |
79 | Vertebral compression fractures (HP:0002953) | 2.38659829 |
80 | Osteomyelitis (HP:0002754) | 2.36472172 |
81 | T lymphocytopenia (HP:0005403) | 2.33771654 |
82 | Encephalitis (HP:0002383) | 2.30393153 |
83 | Purpura (HP:0000979) | 2.30019044 |
84 | Anorexia (HP:0002039) | 2.28063248 |
85 | Thin bony cortex (HP:0002753) | 2.27289944 |
86 | Complement deficiency (HP:0004431) | 2.24746578 |
87 | Gingival bleeding (HP:0000225) | 2.24380212 |
88 | Cerebral inclusion bodies (HP:0100314) | 2.23337962 |
89 | Parakeratosis (HP:0001036) | 2.23104882 |
90 | Neuronal loss in central nervous system (HP:0002529) | 2.21511236 |
91 | Esophageal neoplasm (HP:0100751) | 2.21461056 |
92 | Neoplasm of head and neck (HP:0012288) | 2.21461056 |
93 | Hepatosplenomegaly (HP:0001433) | 2.20353394 |
94 | Osteolytic defects of the hand bones (HP:0009699) | 2.19806467 |
95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19806467 |
96 | Vertigo (HP:0002321) | 2.17836281 |
97 | Bone pain (HP:0002653) | 2.14535340 |
98 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.14279768 |
99 | Dysostosis multiplex (HP:0000943) | 2.13913987 |
100 | Acne (HP:0001061) | 2.13766738 |
101 | Memory impairment (HP:0002354) | 2.11231247 |
102 | Chronic otitis media (HP:0000389) | 2.11096618 |
103 | Gangrene (HP:0100758) | 2.10775110 |
104 | Glomerulonephritis (HP:0000099) | 2.10773082 |
105 | Nephritis (HP:0000123) | 2.10161181 |
106 | Abnormality of the pleura (HP:0002103) | 2.09535357 |
107 | Joint hemorrhage (HP:0005261) | 2.04252381 |
108 | Generalized aminoaciduria (HP:0002909) | 2.02084982 |
109 | Progressive visual loss (HP:0000529) | 2.01785131 |
110 | Pulmonary embolism (HP:0002204) | 2.01109069 |
111 | Keratitis (HP:0000491) | 1.98967250 |
112 | Increased serum ferritin (HP:0003281) | 1.98020863 |
113 | Hematochezia (HP:0002573) | 1.97889542 |
114 | Autoimmune hemolytic anemia (HP:0001890) | 1.97521487 |
115 | Personality changes (HP:0000751) | 1.96154213 |
116 | Hemorrhage of the eye (HP:0011885) | 1.93127478 |
117 | Glomerulopathy (HP:0100820) | 1.92928709 |
118 | Malnutrition (HP:0004395) | 1.92797239 |
119 | Agnosia (HP:0010524) | 1.92515977 |
120 | Prolonged neonatal jaundice (HP:0006579) | 1.92182455 |
121 | Skin ulcer (HP:0200042) | 1.90158074 |
122 | Episodic fever (HP:0001954) | 1.89568728 |
123 | Sepsis (HP:0100806) | 1.89529395 |
124 | Upper motor neuron abnormality (HP:0002127) | 1.89431284 |
125 | Dementia (HP:0000726) | 1.88077113 |
126 | Abnormality of the prostate (HP:0008775) | 1.87148602 |
127 | Pathologic fracture (HP:0002756) | 1.83584905 |
128 | * Arthralgia (HP:0002829) | 1.81871746 |
129 | Cheilitis (HP:0100825) | 1.81457676 |
130 | Lower limb hyperreflexia (HP:0002395) | 1.78147178 |
131 | Eosinophilia (HP:0001880) | 1.75761660 |
132 | Amyloidosis (HP:0011034) | 1.75683818 |
133 | Abnormality of T cell number (HP:0011839) | 1.75070429 |
134 | Abnormality of iron homeostasis (HP:0011031) | 1.73770966 |
135 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.70540482 |
136 | Abnormality of the endocardium (HP:0004306) | 1.70195301 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 4.68880467 |
2 | MAP3K14 | 4.50184557 |
3 | BLK | 4.37696881 |
4 | RIPK4 | 4.16820658 |
5 | TBK1 | 4.02732253 |
6 | IRAK3 | 3.31016877 |
7 | IRAK4 | 2.95949113 |
8 | TYK2 | 2.75668491 |
9 | IKBKE | 2.72294373 |
10 | IKBKB | 2.52295767 |
11 | TXK | 2.51990742 |
12 | ERN1 | 2.30927414 |
13 | JAK3 | 2.27854863 |
14 | TAOK1 | 2.21081435 |
15 | PRPF4B | 2.07711680 |
16 | MAP4K1 | 1.98868300 |
17 | PIM2 | 1.94222223 |
18 | JAK1 | 1.77721233 |
19 | CSK | 1.62815834 |
20 | CHUK | 1.60093470 |
21 | MST4 | 1.59728644 |
22 | KIT | 1.59612779 |
23 | MST1R | 1.56935507 |
24 | FGR | 1.55309583 |
25 | CDC42BPA | 1.47979991 |
26 | BMX | 1.44322537 |
27 | EPHB1 | 1.40961890 |
28 | ABL2 | 1.40720984 |
29 | MAP3K13 | 1.38975809 |
30 | BMPR2 | 1.37297523 |
31 | HCK | 1.22209009 |
32 | SYK | 1.20639260 |
33 | NEK9 | 1.18993232 |
34 | ZAP70 | 1.18643504 |
35 | LYN | 1.15109312 |
36 | NME2 | 1.08627411 |
37 | RPS6KA4 | 1.06619085 |
38 | MATK | 1.06558086 |
39 | MARK3 | 1.06526834 |
40 | LATS2 | 1.01934720 |
41 | EIF2AK2 | 1.00404515 |
42 | SIK3 | 0.98470972 |
43 | EPHA3 | 0.96869640 |
44 | JAK2 | 0.96204458 |
45 | ACVR1B | 0.95148193 |
46 | STK10 | 0.93823947 |
47 | ERBB4 | 0.91461209 |
48 | RIPK1 | 0.91243233 |
49 | PIM1 | 0.89787023 |
50 | ERBB3 | 0.89090201 |
51 | LCK | 0.88474603 |
52 | TYRO3 | 0.87897596 |
53 | MAP3K5 | 0.84981688 |
54 | GRK7 | 0.83548769 |
55 | IRAK1 | 0.79700812 |
56 | PRKCD | 0.78780475 |
57 | FGFR3 | 0.78725284 |
58 | BTK | 0.77033468 |
59 | ARAF | 0.75651715 |
60 | FGFR4 | 0.73269341 |
61 | DYRK3 | 0.71225192 |
62 | TRPM7 | 0.70167226 |
63 | CSF1R | 0.69504253 |
64 | MAP2K6 | 0.68543986 |
65 | ABL1 | 0.68304486 |
66 | YES1 | 0.66728483 |
67 | STK4 | 0.64382548 |
68 | EGFR | 0.64324548 |
69 | LRRK2 | 0.62361862 |
70 | CLK1 | 0.60237261 |
71 | FES | 0.59285228 |
72 | MAP3K1 | 0.59276509 |
73 | CDK6 | 0.58875121 |
74 | ADRBK2 | 0.58807082 |
75 | IRAK2 | 0.57407411 |
76 | TEC | 0.55556059 |
77 | PKN1 | 0.54433013 |
78 | HIPK2 | 0.54273021 |
79 | BMPR1B | 0.53751963 |
80 | MOS | 0.52012409 |
81 | MAPK4 | 0.51448724 |
82 | MAP3K11 | 0.51386813 |
83 | MAP3K12 | 0.51165178 |
84 | TAOK3 | 0.49119414 |
85 | STK24 | 0.47819394 |
86 | DAPK2 | 0.46746675 |
87 | TESK1 | 0.46259084 |
88 | KSR2 | 0.45713655 |
89 | PDGFRA | 0.45581351 |
90 | STK3 | 0.41438961 |
91 | PRKCQ | 0.40454919 |
92 | TRIB3 | 0.39029397 |
93 | PRKG2 | 0.38476778 |
94 | TESK2 | 0.38245123 |
95 | DDR2 | 0.37987776 |
96 | TGFBR2 | 0.37084661 |
97 | FYN | 0.36591112 |
98 | DYRK1B | 0.36223814 |
99 | MAP3K3 | 0.35183602 |
100 | MAPKAPK2 | 0.35121516 |
101 | MAP3K10 | 0.34056692 |
102 | SIK2 | 0.33307045 |
103 | RPS6KL1 | 0.33270447 |
104 | RPS6KC1 | 0.33270447 |
105 | ICK | 0.33124800 |
106 | MAPK7 | 0.31778900 |
107 | PDK1 | 0.30657786 |
108 | DAPK3 | 0.30114722 |
109 | PLK2 | 0.29916106 |
110 | TTN | 0.25700844 |
111 | ADRBK1 | 0.25666783 |
112 | RPS6KA6 | 0.25158722 |
113 | PAK4 | 0.24876173 |
114 | ALK | 0.24198007 |
115 | PTK6 | 0.24044060 |
116 | PDGFRB | 0.23837680 |
117 | CAMKK2 | 0.23442048 |
118 | MUSK | 0.23230801 |
119 | TAOK2 | 0.22686532 |
120 | RPS6KA1 | 0.22540402 |
121 | GSK3A | 0.22430296 |
122 | PDPK1 | 0.22241927 |
123 | CAMK1D | 0.21525593 |
124 | INSR | 0.21144562 |
125 | IGF1R | 0.20052978 |
126 | MET | 0.19171820 |
127 | MAP2K3 | 0.18113353 |
128 | ITK | 0.17772460 |
129 | PIK3CG | 0.17501767 |
130 | CDK14 | 0.15069674 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.09737760 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.56963470 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.05625633 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.04177111 |
5 | Legionellosis_Homo sapiens_hsa05134 | 2.92241874 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.91950973 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.86466636 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.71864633 |
9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.69116569 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.68494632 |
11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.68045972 |
12 | Malaria_Homo sapiens_hsa05144 | 2.59496554 |
13 | Asthma_Homo sapiens_hsa05310 | 2.53600280 |
14 | Pertussis_Homo sapiens_hsa05133 | 2.53348708 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 2.35070626 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.30592452 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26364595 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14250480 |
19 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.11842660 |
20 | Salmonella infection_Homo sapiens_hsa05132 | 2.04268793 |
21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.98521978 |
22 | Measles_Homo sapiens_hsa05162 | 1.93894869 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.82747616 |
24 | Phagosome_Homo sapiens_hsa04145 | 1.68946354 |
25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66429722 |
26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61957751 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58901893 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53806611 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45408218 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.45289151 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39256757 |
32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31357771 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27123141 |
34 | Amoebiasis_Homo sapiens_hsa05146 | 1.19079546 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17415270 |
36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10306763 |
37 | Apoptosis_Homo sapiens_hsa04210 | 1.10026456 |
38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05632927 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04804913 |
40 | Shigellosis_Homo sapiens_hsa05131 | 1.04547623 |
41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04359599 |
42 | Hepatitis C_Homo sapiens_hsa05160 | 0.98998602 |
43 | Prion diseases_Homo sapiens_hsa05020 | 0.98156824 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 0.96954159 |
45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90346503 |
46 | Bladder cancer_Homo sapiens_hsa05219 | 0.90170847 |
47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86270840 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83993351 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83066864 |
50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77777898 |
51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75527464 |
52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75312738 |
53 | Mineral absorption_Homo sapiens_hsa04978 | 0.70564813 |
54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69817858 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67645075 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65846849 |
57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62929135 |
58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61070986 |
59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57763891 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56934580 |
61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56523441 |
62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55041606 |
63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52220625 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50314201 |
65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47566115 |
66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44411979 |
67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44305232 |
68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41938235 |
69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40540365 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39626890 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38851088 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38189354 |
73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35723726 |
74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35132573 |
75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34628843 |
76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34515412 |
77 | Platelet activation_Homo sapiens_hsa04611 | 0.34039770 |
78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32009067 |
79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31400789 |
80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31129368 |
81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30987484 |
82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30363613 |
83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29888921 |
84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29870649 |
85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29442305 |
86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26327274 |
87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26152320 |
88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25342077 |
89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25311484 |
90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24375341 |
91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20145881 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20032945 |
93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19360263 |
94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17594278 |
95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17017047 |
96 | Insulin resistance_Homo sapiens_hsa04931 | 0.16761629 |
97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16256094 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13553439 |
99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12414733 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10901267 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10670979 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.10422512 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10147499 |
104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.09437641 |
105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08503612 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08399882 |
107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.08038349 |
108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.07960730 |
109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.06821260 |
110 | Proteasome_Homo sapiens_hsa03050 | 0.06693916 |
111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.06377557 |
112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.06180175 |
113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.04914996 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04029077 |